EXPRESSION OF TUMOR-NECROSIS-FACTOR (TNF-ALPHA) AND ITS RECEPTORS IN BENIGN AND MALIGNANT BREAST-TISSUE

被引:118
作者
MILES, DW [1 ]
HAPPERFIELD, LC [1 ]
NAYLOR, MS [1 ]
BOBROW, LG [1 ]
RUBENS, RD [1 ]
BALKWILL, FR [1 ]
机构
[1] IMPERIAL CANC RES FUND,LINCOLNS INN FIELDS,LONDON WC2A 3PX,ENGLAND
关键词
D O I
10.1002/ijc.2910560603
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
As well as having anti-tumour activity in animal models, TNF alpha has been implicated in the promotion of tumour invasion and metastasis. Expression and localization of TNF alpha mRNA and protein has been investigated in a series of benign and malignant breast tissues. TNF alpha mRNA was expressed in a minority of cells (<0.5%) in 4/11 cases of benign breast tissue and in a higher proportion of invasive carcinomas (43/49 cases). Expression of TNF alpha mRNA was focal and confined to the tumour stroma. The presence of TNF alpha protein was confirmed by immunohistochemistry and again was predominantly stromal. Expression of mRNA and protein localized to infiltrating macrophages defined by the antibody EBM/11 in adjacent sections and using 2-colour immunofluoresence. Although the average number of macrophages per high-power field did not vary among invasive carcinomas of different histological type or grade, the number of cells expressing TNF alpha increased with increasing tumour grade. Immunodetectable p75 TNF receptor and to a lesser extent p55 receptor was present on cells of the mononuclear infiltrate and on the endothelium of invasive carcinomas, but not on the tumour cells themselves. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:777 / 782
页数:6
相关论文
共 27 条
[1]   ENHANCEMENT OF EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION ON GLIOMA-CELLS BY RECOMBINANT TUMOR-NECROSIS-FACTOR-ALPHA [J].
ADACHI, K ;
BELSER, P ;
BENDER, H ;
LI, DR ;
RODECK, U ;
BENVENISTE, EN ;
WOO, D ;
SCHMIEGEL, WH ;
HERLYN, D .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1992, 34 (06) :370-376
[2]  
Balkwill Frances R., 1992, Progress in Growth Factor Research, V4, P121, DOI 10.1016/0955-2235(92)90027-F
[3]   IDENTIFICATION OF 2 TYPES OF TUMOR-NECROSIS-FACTOR RECEPTORS ON HUMAN CELL-LINES BY MONOCLONAL-ANTIBODIES [J].
BROCKHAUS, M ;
SCHOENFELD, HJ ;
SCHLAEGER, EJ ;
HUNZIKER, W ;
LESSLAUER, W ;
LOETSCHER, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (08) :3127-3131
[4]   DEXAMETHASONE PREVENTS THE GROWTH INHIBITORY EFFECTS OF RECOMBINANT TUMOR-NECROSIS-FACTOR IN A RAT HEPATOMA-CELL LINE REUBER-RC-3 - AN ASSOCIATION WITH THE CHANGES IN THE MESSENGER-RNA LEVELS FOR MULTIDRUG RESISTANCE GENE [J].
CHAPEKAR, MS ;
HUGGETT, AC ;
CHENG, C .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 181 (03) :1524-1531
[5]   IMMUNOENZYMATIC LABELING OF MONOCLONAL-ANTIBODIES USING IMMUNE-COMPLEXES OF ALKALINE-PHOSPHATASE AND MONOCLONAL ANTI-ALKALINE PHOSPHATASE (APAAP COMPLEXES) [J].
CORDELL, JL ;
FALINI, B ;
ERBER, WN ;
GHOSH, AK ;
ABDULAZIZ, Z ;
MACDONALD, S ;
PULFORD, KAF ;
STEIN, H ;
MASON, DY .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1984, 32 (02) :219-229
[6]   ACTIVITY OF TYPE-IV COLLAGENASES IN BENIGN AND MALIGNANT BREAST DISEASE [J].
DAVIES, B ;
MILES, DW ;
HAPPERFIELD, LC ;
NAYLOR, MS ;
BOBROW, LG ;
RUBENS, RD ;
BALKWILL, FR .
BRITISH JOURNAL OF CANCER, 1993, 67 (05) :1126-1131
[7]   THE ASSESSMENT OF HISTOLOGICAL DIFFERENTIATION IN BREAST-CANCER [J].
ELSTON, CW .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1984, 54 (01) :11-15
[8]   TUMOR-NECROSIS-FACTOR - CHARACTERIZATION AT THE MOLECULAR, CELLULAR AND INVIVO LEVEL [J].
FIERS, W .
FEBS LETTERS, 1991, 285 (02) :199-212
[9]  
HOGG N, 1990, LEUCOCYTE TYPING, V4, P592
[10]  
LAKE FR, 1992, FASEB J, V6, pA1614